INS and metabolic dysfunction-associated steatohepatitis: Another mechanism is the reduced hepatic de novo lipogenesis in vivo, which is a key component of hepatic lipid accumulation in NASH [19]; one more potential mechanism is their potential anti-lipogenic action on hepatocytes and restoration of hepatic insulin sensitivity.